Our findings support that E. coli increases the malignancy of ICC by upregulating the expression of splicing factor eIF4A3, thereby promoting the assembly of SGs and leading to sustained activation of the NF‐κB pathway. The gene discussed is NFKB1; the disease is intrahepatic cholangiocarcinoma.